These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35259461)

  • 1. DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation.
    Leung AWY; Chen KTJ; Ryan GM; Anantha M; Wretham N; Nosrati Z; Heroux D; Wang L; Chow N; Dai Z; Bally MB
    J Control Release; 2022 May; 345():75-90. PubMed ID: 35259461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor.
    Leung AWY; Anantha M; Dragowska WH; Wehbe M; Bally MB
    J Control Release; 2018 Sep; 286():1-9. PubMed ID: 30016731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
    Lim HJ; Masin D; Madden TD; Bally MB
    J Pharmacol Exp Ther; 1997 Apr; 281(1):566-73. PubMed ID: 9103545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a novel flavopiridol formulation for treatment of acute myeloid leukemia.
    Chen KTJ; Militao GGC; Anantha M; Witzigmann D; Leung AWY; Bally MB
    J Control Release; 2021 May; 333():246-257. PubMed ID: 33798663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
    Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of transition metal-doxorubicin complexes inside liposomes.
    Abraham SA; Edwards K; Karlsson G; MacIntosh S; Mayer LD; McKenzie C; Bally MB
    Biochim Biophys Acta; 2002 Sep; 1565(1):41-54. PubMed ID: 12225851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of liposomal topotecan for use in treating neuroblastoma.
    Chernov L; Deyell RJ; Anantha M; Dos Santos N; Gilabert-Oriol R; Bally MB
    Cancer Med; 2017 Jun; 6(6):1240-1254. PubMed ID: 28544814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
    Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
    Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Study of Liposomal Formulations to Improve the Delivery of Aquated Cisplatin to a Multidrug Resistant Tumor.
    Zhao Y; May JP; Chen IW; Undzys E; Li SD
    Pharm Res; 2015 Oct; 32(10):3261-8. PubMed ID: 25964047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
    Ramsay E; Alnajim J; Anantha M; Zastre J; Yan H; Webb M; Waterhouse D; Bally M
    Eur J Pharm Biopharm; 2008 Mar; 68(3):607-17. PubMed ID: 17904831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ni2+-mediated mitoxantrone encapsulation: improved efficacy of fast release formulation.
    Cui J; Li C; Wang L; Wang C; Yang H; Li Y; Zhang L; Zhang L; Guo W; Liang M
    Int J Pharm; 2009 Feb; 368(1-2):24-30. PubMed ID: 18973800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze-drying cycle optimization for the rapid preservation of protein-loaded liposomal formulations.
    Hussain MT; Forbes N; Perrie Y; Malik KP; Duru C; Matejtschuk P
    Int J Pharm; 2020 Jan; 573():118722. PubMed ID: 31705976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.
    Chen KTJ; Anantha M; Leung AWY; Kulkarni JA; Militao GGC; Wehbe M; Sutherland B; Cullis PR; Bally MB
    Drug Deliv Transl Res; 2020 Feb; 10(1):202-215. PubMed ID: 31482519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.
    Webb MS; Boman NL; Wiseman DJ; Saxon D; Sutton K; Wong KF; Logan P; Hope MJ
    Antimicrob Agents Chemother; 1998 Jan; 42(1):45-52. PubMed ID: 9449259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity.
    Pereira S; Egbu R; Jannati G; Al-Jamal WT
    Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver.
    Lim HJ; Parr MJ; Masin D; McIntosh NL; Madden TD; Zhang G; Johnstone S; Bally MB
    Clin Cancer Res; 2000 Nov; 6(11):4449-60. PubMed ID: 11106266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.